An 81-year-old man with imbalance and memory impairment
暂无分享,去创建一个
[1] M. Greicius,et al. Non-Fluent Progressive Aphasia, Depression, and OCD in a Woman With Progressive Supranuclear Palsy: Neuroanatomical and Neuropathological Correlations , 2006, Neurocase.
[2] D. Dickson,et al. The relationship between histopathological features of progressive supranuclear palsy and disease duration. , 2006, Parkinsonism & related disorders.
[3] Joseph James Duffy,et al. Atypical progressive supranuclear palsy underlying progressive apraxia of speech and nonfluent aphasia , 2005, Neurocase.
[4] A. Lees,et al. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. , 2005, Brain : a journal of neurology.
[5] D. Burn. Commentary on: Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism, by D. Williams, R. de Silva, D. Paviour, et al. (Brain-2004-01045.R1). , 2005, Brain : a journal of neurology.
[6] E. Cochran,et al. Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders , 2004 .
[7] K. Arai,et al. Study of the rostral midbrain atrophy in progressive supranuclear palsy , 2003, Journal of the Neurological Sciences.
[8] M. Hallett,et al. Randomized placebo-controlled trial of donepezil in patients with progressive supranuclear palsy , 2001, Neurology.
[9] C. Colosimo,et al. Donepezil in the treatment of progressive supranuclear palsy , 2001, Acta neurologica Scandinavica.
[10] F. Tison,et al. Oral zolmitriptan is effective in the acute treatment of cluster headache , 2000, Neurology.
[11] I Litvan,et al. Association of an extended haplotype in the tau gene with progressive supranuclear palsy. , 1999, Human molecular genetics.
[12] M. Hallett,et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) , 1996, Neurology.
[13] I Litvan,et al. Preliminary NINDS neuropathologic criteria for Steele‐Richardson‐Olszewski syndrome (progressive supranuclear palsy) , 1994, Neurology.
[14] R. Leigh,et al. The syndrome of 'pure akinesia' and its relationship to progressive supranuclear palsy , 1994, Neurology.
[15] E. Tangalos,et al. The short test of mental status. Correlations with standardized psychometric testing. , 1991, Archives of neurology.
[16] A. Delacourte,et al. Abnormal Tau proteins in progressive supranuclear palsy , 1991, Acta Neuropathologica.
[17] L. Golbe,et al. Prevalence and natural history of progressive supranuclear palsy , 1988, Neurology.
[18] K P Offord,et al. A short test of mental status: description and preliminary results. , 1987, Mayo Clinic proceedings.
[19] F Lhermitte,et al. Heterogeneity of cognitive impairment in progressive supranuclear palsy, Parkinson's disease, and Alzheimer's disease , 1986, Neurology.
[20] B. Troost,et al. The ocular motor defects in progressive supranuclear palsy , 1977, Annals of neurology.
[21] H. Braak,et al. Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.
[22] Irene Litvan,et al. Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia , 2003, Annals of neurology.